로딩 중…
StockDiggingStockDigging

HLscience Co., Ltd.

239610· KOSDAQ
₩5,640-3.75%
2026-06-19

Price Chart

HLscience Co., Ltd.-53.92%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap30.41B KRW
Revenue13.76B KRW
Net Income-3.96B KRW
Total Assets83.16B KRW
Net Assets80.89B KRW
Employees84
Value
P/B0.38x
P/S2.21x
FCF Yield-24.70%
Profitability
ROE-4.90%
ROA-4.77%
Op. Margin-12.21%
Revenue Growth-57.97%
Financial Health
Debt Ratio102.81%
Total Debt0 KRW
FCF-7.51B KRW
Cash1.68B KRW
Current Ratio15.16x
Dividend
Div. Growth0.00%
Performance
1Y Return-53.92%
1M Return-24.80%
From 52W High-59.07%
1Y MDD-57.31%
Trading
Volume1,177 shares
Foreign Own.0.88%
Per Share
EPS-2,095 KRW
BPS15,855 KRW

Company Info

CEO 이해연
Employees 84
Founded 2000
HQ 경기도 의왕시, KR

HL Science, originally Geongang Sarang, was founded in 2000 and listed on KOSDAQ in 2016. In 2022, it completed Korea's first Ministry of Food and Drug Safety-approved individually recognized raw material CDMO smart factory in Chungju, Chungcheongbuk-do. The company operates as a technology platform enterprise, focusing on research into new biomaterials and new technologies for bio healthcare, encompassing R&D, manufacturing, and sales. It has developed 12 individually recognized raw materials, securing 48 domestic and international patent registrations and 16 patent applications, establishing an integrated Value Chain system. Headquartered in Uiwang, Gyeonggi-do.